NovoCure (NASDAQ:NVCR) Shares Gap Up After Analyst Upgrade

NovoCure Limited (NASDAQ:NVCR – Get Free Report)’s stock price gapped up prior to trading on Friday after Piper Sandler raised their price target on the stock from $28.00 to $42.00. The stock had previously closed at $30.06, but opened at $31.22. Piper Sandler currently has an overweight rating on the stock. NovoCure shares last traded […]

Leave a Reply

Your email address will not be published.

Previous post Capasso Planning Partners LLC Purchases 5,204 Shares of Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM)
Next post Semtech (NASDAQ:SMTC) Stock Price Up 6% Following Analyst Upgrade